Skip to main content
. 2020 Feb 15;8(4):704–708. doi: 10.1002/ccr3.2737

Table 3.

Table showing tumor lysis syndrome risk categories for prophylaxis

Low risk Intermediate risk High risk
Most solid tumors Neuroblastoma, germ cell tumor, small cell lung cancer Burkitt's leukemia
Multiple myeloma Plasma cell leukemia Acute myeloid leukemia with a WBC count >100 × 109/L
Chronic myeloid leukemia Acute myeloid leukemia with a WBC count of 25‐100 × 109/L Acute lymphoblastic leukemia with a WBC count >100 × 109/L
Chronic lymphoid leukemia Adult T cell leukemia/Lymphoma Stage III and IV lymphomas

Adult intermediate

Non‐Hodgkin's lymphoma with normal HDL

Acute lymphoblastic leukemia with WBC count <100 × 109/L Renal dysfunction
    Preexisting hyperuricemia and hyperphosphatemia